Aim: To demonstrate the efficacy of uterine artery embolization in the management of postpartum hemorrhage (PPH) due to pseudoaneurysm of the uterine artery. Background: Postpartum hemorrhage is a leading cause of maternal mortality in India. Secondary PPH is a rare cause but potentially life threatening. Common causes of secondary PPH are retained products of conception, subinvolution of uterus, and endometritis. Pseudoaneurysm is an uncommon cause of secondary PPH following operative delivery. Color Doppler ultrasound is a useful diagnostic tool and angiography is necessary to localize and treat by embolization. Case report: We report two cases of secondary PPH due to pseudoaneurysm of uterine artery, which were managed by selective embolization of uterine artery. Conclusion: Angiographic embolization of uterine artery is a safe and reliable technique for management of secondary PPH due to pseudoaneurysm. If diagnosed early, the need for hysterectomy is prevented. Clinical significance: Uterine artery embolization has emerged as a simple, effective, and fertility-sparing treatment for PPH.
BACKGROUND Abnormal uterine bleeding is defined as any bleeding not conforming to the normal cyclical pattern as well as to the normal amount and frequency of menstrual cycle. Abnormal uterine bleeding can occur due to gynaecological as well as medical causes. Gynaecological causes include organic and nonorganic factors. It has various clinical presentations such as menorrhagia, polymenorrhagia, metrorrhagia and intermenstrual bleeding. Dilatation and Curettage (D and C) is a safe and effective outpatient procedure performed in patients with AUB. It provides endometrial tissue for examination of histological variations of endometrium thus guiding in further management. MATERIALS AND METHODS This is a retrospective study of patients presenting with AUB over a period of one year (2015-2016) done in the Department of Obstetrics and Gynaecology at a tertiary care hospital. 89 patients with complaints of AUB attributable to isolated endometrial cause were included in the study. Patients with AUB due to vaginal, cervical causes, leiomyomas, adnexal pathology, medical causes and complications of pregnancy were excluded from the study. A structured proforma regarding the patient's complaints, pattern of bleeding, medical, surgical history and a general systemic and pelvic examination was used to evaluate all patients. RESULTS Among all the patients who presented with AUB during the study period, 89 patients were identified to have isolated endometrial pathology as a cause of abnormal uterine bleeding. In our study, age of patients presenting with AUB ranged from 24 years to 70 years. AUB was most commonly seen in the age group of 41-50 years (42.6%). Menorrhagia in 32.5% was the most common presentation of AUB. The commonest histopathological finding was proliferative phase endometrium (25.84%) followed by secretory phase endometrium (19.1%). Hyperplasia was observed in 19.1%, which included simple hyperplasia (6.74%), complex hyperplasia without atypia in 2.24% of women and complex hyperplasia with atypia in 10.11%. Glandular stromal dissociation and endometrial polyp each were observed in 7.86% of patients. Disordered proliferative endometrium was observed in 4.49% of patients. Chronic endometritis was seen in 4.5% of cases, which included 2.2% of tuberculous endometritis. Endometrial carcinoma was observed in 2.24% of patients. CONCLUSIONS Organic causes of AUB vary according to the age group. Endometrial sampling by D and C is a simple, reliable outpatient procedure to diagnose endometrial lesions. Histopathological examination of the obtained material during the procedure can help in diagnosing the proliferative lesions at an early stage and subsequent treatment preventing its further progression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.